Archive:Facial Autologous Muscular Injection: Difference between revisions

mNo edit summary
unsourced and promotional content
Line 3: Line 3:


==History==
==History==
Fat transplantation procedures have been in use for decades to restore volume to the face, and as a result, various techniques have been developed over the years.<ref name=cambridge>{{cite web| url=http://ebooks.cambridge.org/chapter.jsf?bid=CBO9780511674839&cid=CBO9780511674839A037| title=FAMI TECHNIQUE AND FAT TRANSFER FOR HAND REJUVENATION| author=Kimberly J. Butterwick| date=July 2010| publisher=Cambridge University Press| accessdate=25 October 2014}}</ref> Facial autologous muscular injection (FAMI) was developed from 1996 by Roger E. Amar M.D., a French plastic surgeon.<ref name=cambridge /><ref name=foxmd>{{cite journal| title=The facial autologous muscular injection (FAMI) procedure: an anatomically targeted deep multiplane autologous grafting technique using principles of adipose stem cell injection| last1=Amar| first1=Roger| last2=Fox| first2=Donald| date=August 2011| journal=Aesthetic Plast Surg| pmid=21298265| doi=10.1007/s00266-010-9645-0| volume=35| pages=502–10}}</ref> Roger  Amar is the founder and director of the AMARCLINIC which hosts the FAMI international Academy in [[Marbella]], [[Spain]].<ref name=dermatimes2>{{cite web| url=http://dermatologytimes.modernmedicine.com/user/login?destination=node%2F334562&nid=334562| title=FAMI technique adds fullness to cheeks| author=Jane Schwanke| date=1 January 2005| publisher=Dermatology Times| accessdate=25 October 2014}}</ref> FAMI was introduced to the [[United States]] in 2001,<ref name=cambridge /> and in 2010 in London UK. The FAMI procedure differs from other fat transplantation procedures in that it takes the patient's facial vascular paths into account while using their own fatty tissue to address the loss of volume in the face without having to make incisions. A specific instrumentation is needed. 13 non traumatic blunt needles called cannulas were designed according to the skull curvatures and each mimic muscle.
Fat transplantation procedures have been in use for decades to restore volume to the face, and as a result, various techniques have been developed over the years.<ref name=cambridge>{{cite web| url=http://ebooks.cambridge.org/chapter.jsf?bid=CBO9780511674839&cid=CBO9780511674839A037| title=FAMI TECHNIQUE AND FAT TRANSFER FOR HAND REJUVENATION| author=Kimberly J. Butterwick| date=July 2010| publisher=Cambridge University Press| accessdate=25 October 2014}}</ref> Facial autologous muscular injection (FAMI) was developed from 1996 by Roger E. Amar M.D., a French plastic surgeon.<ref name=cambridge /><ref name=foxmd>{{cite journal| title=The facial autologous muscular injection (FAMI) procedure: an anatomically targeted deep multiplane autologous grafting technique using principles of adipose stem cell injection| last1=Amar| first1=Roger| last2=Fox| first2=Donald| date=August 2011| journal=Aesthetic Plast Surg| pmid=21298265| doi=10.1007/s00266-010-9645-0| volume=35| pages=502–10}}</ref> Roger  Amar is the founder and director of the AMARCLINIC which hosts the FAMI international Academy in [[Marbella]], [[Spain]].<ref name=dermatimes2>{{cite web| url=http://dermatologytimes.modernmedicine.com/user/login?destination=node%2F334562&nid=334562| title=FAMI technique adds fullness to cheeks| author=Jane Schwanke| date=1 January 2005| publisher=Dermatology Times| accessdate=25 October 2014}}</ref> FAMI was introduced to the [[United States]] in 2001,<ref name=cambridge /> and in 2010 in London UK. The FAMI procedure differs from other fat transplantation procedures in that it takes the patient's facial vascular paths into account while using their own fatty tissue to address the loss of volume in the face without having to make incisions.


==Indications==
==Indications==
Line 18: Line 18:


==Complications==
==Complications==
Complications from facial autologous muscular injections are very rare due to the very precision of the injections. In trained hands, bruising is not frequent which means that tissue destruction is minimal. In “2011 Advanced Techniques in Liposuction and Fat Transfer report”, it was reported that the 726 cases over 14 years were free of complications such as cytosteatonecrosis, [[cyst]] formation, infections or other issues. <ref name=intechopen />.
Complications from facial autologous muscular injections are very rare. The procedure is  minimally invasive and does not require the use of general [[anesthesia]], however, local anesthesia is used to block the patient from feeling pain or discomfort. FAMI procedures are not surgical, it is an outpatient procedure done outside of a hospital. From the 2011 Advanced Techniques in Liposuction and Fat Transfer report, it was noted that in 726 cases over 14 years there were no reports of complications such as cytosteatonecrosis, [[pseudocyst]] formation, infections or other issues.<ref name=intechopen />
 
==Conclusion==
The FAMI procedure is non-invasive and does not require the use of general [[anaesthesia]], however, local block anaesthesia with slight sedation is used to prevent pain or discomfort in an outpatient basis. In 2017, after 20 years surgeons are considered FAMI as a very safe procedure for them and their patients. They praise  the technique for its 2 main advantages: Predictability and Longevity.


==See also==
==See also==